Multi-omics landscape and clinical significance of a <i>SMAD4</i>-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer.

Comput Struct Biotechnol J · 2022 · PMC8908051 · PMID 35317237

Europe PMC DOI

hedged sentence

0.3200

closest p · 6.4× alpha

0.3200

boldest claim

The sentences

did not reach statistical significanceP = 0.32not close (p > 0.1)

TMB also showed a corresponding trend, but the difference did not reach statistical significance (P = 0.32, Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.